Par argatroban recall: steel and plastic particles in 22 lots
Par Health recalled argatroban injection 250 mg/2.5 mL after finding particles of cellulose, plastics, stainless steel and stopper material. FDA classed it Class I.
Is your product on this list?
Products at risk. Who's in.
Recalledin the firm's recall notice
| MOLECULE | FORM | SOLD IN THE US BY | LINK TO SITE | RISK | WHO'S IN | Action |
|---|---|---|---|---|---|---|
| Argatroban | Injection 250 mg/2.5 mL, single-dose vial | Par / Endo | RECALLED | RECALLED | 11 API (8 US DMF) · 9 FDF | See who's in |
FDA often redacts product names in its letters. Rows marked "FDA label" come from openFDA drug labels that name this site. "Who's in" counts manufacturers of the same molecule in the API-FDF database; names and contacts are inside.
What FDA found
- Particles identified as cellulose, polystyrene, polyethylene terephthalate, stainless steel or stopper material in the solution.
- 22 lots and 20,935 vials shipped nationwide, with expiry dates from October 2026 to September 2027.
- Recall started on 13 October 2026. FDA posted it as Class I on 28 October.
Timeline
How it got here
13 OCT 2026
Par starts the recall
28 OCT 2026
FDA posts it as Class I